Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, The University of Texas Health Science Center at Houston, 77030, USA.
Am J Perinatol. 2012 Feb;29(2):147-52. doi: 10.1055/s-0031-1295656. Epub 2011 Nov 21.
The objective of this study was to compare the frequency of abnormal fetal growth in women with diabetes mellitus (DM) using population-based birth weight (pop BW) percentiles compared with customized birth weight (cust BW) percentiles, which include adjustments for maternal race, parity, height, weight, and fetal sex. The study design comprised a retrospective cohort of singleton DM pregnancies delivered over a 1-year period (June 2007 to May 2008) from a single tertiary care university-based medical center. Inclusion criteria were gestational age >20 weeks at delivery, live birth, and absence of major chromosomal/structural abnormalities. Small for gestational age (SGA), <10th percentile, and large for gestational age (LGA), >90th percentile pregnancies were categorized based on pop BW or cust BW standards. There were significant differences in the rates of SGA (p < 0.004) and LGA (p < 0.001) between cust BW and pop BW methods. When comparing the two methods, pop BW did not identify 13/16 (81%) of SGA and 23/39 (59%) of LGA babies defined by cust BW methods. The use of cust BW calculation in a diabetic population identified a greater percentage of neonates with pathologic fetal growth compared with pop BW standards, suggesting that the population standard may underdiagnose abnormal fetal growth in diabetic pregnancies.
本研究旨在比较基于人群的出生体重(pop BW)百分位与定制化出生体重(cust BW)百分位在诊断糖尿病(DM)孕妇胎儿生长异常中的频率差异,后者考虑了母亲种族、产次、身高、体重和胎儿性别等因素的调整。研究设计包括对 2007 年 6 月至 2008 年 5 月期间在单一三级保健大学医学中心分娩的单胎 DM 妊娠进行的回顾性队列研究。纳入标准为分娩时孕龄>20 周、活产且无主要染色体/结构异常。根据 pop BW 或 cust BW 标准,将小于胎龄儿(SGA)<第 10 百分位和大于胎龄儿(LGA)>第 90 百分位的妊娠进行分类。cust BW 和 pop BW 方法在 SGA(p<0.004)和 LGA(p<0.001)的发生率方面存在显著差异。当比较两种方法时,pop BW 未能识别出 cust BW 方法定义的 16 例 SGA 中的 13 例(81%)和 39 例 LGA 中的 23 例(59%)。在糖尿病患者中使用 cust BW 计算方法,与 pop BW 标准相比,识别出更多具有病理性胎儿生长的新生儿,表明人群标准可能低估了糖尿病妊娠中的胎儿生长异常。